In the results reported herein, the blood EPO and G-CSF levels in the BDS group were lower than the control group but increased significantly upon SPSP administration, indicating that SPSP might alleviate hematopoietic damage by promoting EPO and G-CSF production. The gene discussed is CSF3; the disease is Diamond-Blackfan anemia.